Surgical treatment of clinical stage A nonseminomatous testis cancer

Richard Foster, John P. Donohue

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Until clinical staging improves, patients presenting with clinical stage A nonseminomatous testis cancer should be offered the option of initial nerve-sparing RPLND versus surveillance. Either method of management may be successful in the individual patient. We feel each patient with clinical stage A disease must be informed of alternative methods of management and be allowed to choose the method of management that he feels best suits his needs in terms of risk benefit.

Original languageEnglish
Pages (from-to)166-170
Number of pages5
JournalSeminars in Oncology
Volume19
Issue number2
StatePublished - 1992

Fingerprint

Testicular Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Oncology

Cite this

Surgical treatment of clinical stage A nonseminomatous testis cancer. / Foster, Richard; Donohue, John P.

In: Seminars in Oncology, Vol. 19, No. 2, 1992, p. 166-170.

Research output: Contribution to journalArticle

@article{4f2c2d066e574d73a40a242a2c9fa939,
title = "Surgical treatment of clinical stage A nonseminomatous testis cancer",
abstract = "Until clinical staging improves, patients presenting with clinical stage A nonseminomatous testis cancer should be offered the option of initial nerve-sparing RPLND versus surveillance. Either method of management may be successful in the individual patient. We feel each patient with clinical stage A disease must be informed of alternative methods of management and be allowed to choose the method of management that he feels best suits his needs in terms of risk benefit.",
author = "Richard Foster and Donohue, {John P.}",
year = "1992",
language = "English",
volume = "19",
pages = "166--170",
journal = "Seminars in Oncology",
issn = "0093-7754",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Surgical treatment of clinical stage A nonseminomatous testis cancer

AU - Foster, Richard

AU - Donohue, John P.

PY - 1992

Y1 - 1992

N2 - Until clinical staging improves, patients presenting with clinical stage A nonseminomatous testis cancer should be offered the option of initial nerve-sparing RPLND versus surveillance. Either method of management may be successful in the individual patient. We feel each patient with clinical stage A disease must be informed of alternative methods of management and be allowed to choose the method of management that he feels best suits his needs in terms of risk benefit.

AB - Until clinical staging improves, patients presenting with clinical stage A nonseminomatous testis cancer should be offered the option of initial nerve-sparing RPLND versus surveillance. Either method of management may be successful in the individual patient. We feel each patient with clinical stage A disease must be informed of alternative methods of management and be allowed to choose the method of management that he feels best suits his needs in terms of risk benefit.

UR - http://www.scopus.com/inward/record.url?scp=0026513539&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026513539&partnerID=8YFLogxK

M3 - Article

VL - 19

SP - 166

EP - 170

JO - Seminars in Oncology

JF - Seminars in Oncology

SN - 0093-7754

IS - 2

ER -